Strength Training in Fibromyalgia on Balance, Neuromuscular Performance and Symptoms
Does Strength Training in Fibromyalgia Affect Balance, Neuromuscular Performance and Symptoms? A 12 Week of a Randomized Controlled Trial
1 other identifier
interventional
57
1 country
1
Brief Summary
The purpose of this study is verify the effects of a 8 weeks strength training, on balance, neuromuscular performance and symptomatology of fibromyalgia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2022
CompletedFirst Posted
Study publicly available on registry
December 12, 2022
CompletedStudy Start
First participant enrolled
October 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 7, 2025
CompletedDecember 31, 2025
December 1, 2025
10 months
November 29, 2022
December 26, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
Balance
Force plate
Change from Baseline balance at week 9
Balance
Force plate
Change from Baseline balance at week 12
Balance
Force plate
Change from week 9 balance at week 12
Neuromuscular performance
Optical measurement system consisting of two transmitting and receiving cells to assess vertical jump and medicine ball to assess strength of the upper limbs.
Change from Baseline neuromuscular performance at week 9
Neuromuscular performance
Optical measurement system consisting of two transmitting and receiving cells to assess vertical jump and medicine ball to assess strength of the upper limbs.
Change from Baseline neuromuscular performance at week 12
Neuromuscular performance
Optical measurement system consisting of two transmitting and receiving cells to assess vertical jump and medicine ball to assess strength of the upper limbs.
Change from week 9 neuromuscular performance at week 12
Secondary Outcomes (6)
Fibromyalgia impact questionnaire
Baseline, week 9, week 12
Pain intensity
baseline and everyday until the week 12
Anxiety
baseline and everyday until the week 12
Quality of sleep
baseline and everyday until the week 12
Fatigue
baseline and everyday until the week 12
- +1 more secondary outcomes
Study Arms (2)
Exercise
EXPERIMENTAL8 weeks of strength training.
Control
NO INTERVENTIONMaintain their usual medical treatment and daily routines
Interventions
The protocol consists of 8 weeks of training, consisting of 16 sessions of 50 minutes, twice a week on alternate days.
Eligibility Criteria
You may qualify if:
- medical diagnosis of fibromyalgia according to the American College of Rheumatology criteria
- at least 18 years old
You may not qualify if:
- severe comorbidity or any other type of condition that negatively influences participation in the training program
- cognitive disorders
- heart problems
- surgeries or fractures in the last 6 months
- regular practice of physical exercises in the least 3 months before program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Beira Interiorlead
- Universidade Federal de Pernambucocollaborator
Study Sites (1)
Federal University of Pernambuco
Recife, Pernambuco, 50670-901, Brazil
Related Publications (1)
Albuquerque MLL, Monteiro D, Alvarez MC, Vilarino GT, Andrade A, Neiva HP. Effects of strength training in fibromyalgia on balance, neuromuscular performance, and symptomatic analysis: a 12-week study protocol. Front Neurol. 2023 Apr 28;14:1149268. doi: 10.3389/fneur.2023.1149268. eCollection 2023.
PMID: 37188309DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Investigator
University of Beira Interior
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 29, 2022
First Posted
December 12, 2022
Study Start
October 5, 2024
Primary Completion
August 7, 2025
Study Completion
August 7, 2025
Last Updated
December 31, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share